S100B/RAGE/Ceramide signaling pathway is involved in sepsis-associated encephalopathy.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Jul 2021
Historique:
received: 15 09 2020
revised: 26 03 2021
accepted: 30 03 2021
pubmed: 17 4 2021
medline: 23 6 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Sepsis-associated encephalopathy (SAE) is one of the most common complications of sepsis, and it might lead to long-term cognitive dysfunction and disability. This study aimed to explore the role of S100 calcium binding protein B (S100B)/RAGE/ceramide signaling pathway in SAE. FPS-ZM1 (an inhibitor of RAGE), myriocin and GW4869 (an inhibitor of ceramide) were used to explore the role of S100B/RAGE/ceramide in acute brain injury and long-term cognitive impairment in sepsis. In addition, Mdivi-1 (inhibitor of Drp1) and Drp1 siRNA were utilized to assess the effects of C2-ceramide on neuronal mitochondria, and to explore the specific underlying mechanism in C2 ceramide-induced death of HT22 mouse hippocampal neuronal cells. Western blot analysis showed that sepsis significantly up-regulated S100B and RAGE. Nissl staining and Morris water maze (MWM) test revealed that inhibition of RAGE with FPS-ZM1 markedly attenuated cecal ligation and puncture (CLP)-induced brain damage and cognitive dysfunction. Furthermore, FPS-ZM1 relieved sepsis-induced C2-ceramide accumulation and abnormal mitochondrial dynamics. Moreover, inhibition of ceramide also showed similar protective effects both in vivo and in vitro. Furthermore, Mdivi-1 and Drp1 siRNA significantly reduced C2-ceramide-induced neuronal mitochondrial fragmentation and cell apoptosis in vitro. This study confirmed that S100B regulates mitochondrial dynamics through RAGE/ceramide pathway, in addition to the role of this pathway in acute brain injury and long-term cognitive impairment during sepsis.

Identifiants

pubmed: 33862114
pii: S0024-3205(21)00475-6
doi: 10.1016/j.lfs.2021.119490
pii:
doi:

Substances chimiques

Ceramides 0
Receptor for Advanced Glycation End Products 0
S100 Calcium Binding Protein beta Subunit 0
S100b protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119490

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Lina Zhang (L)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: zln7095@csu.edn.cn.

Yuan Jiang (Y)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.

Songyun Deng (S)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: dengsy2014@csu.edn.cn.

Yunan Mo (Y)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: MoyuNan@csu.edu.cn.

Yan Huang (Y)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: 178111079@csu.edu.cn.

Wenchao Li (W)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: 178101067@csu.edu.cn.

Chenglong Ge (C)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: 198102166@csu.edu.cn.

Xinshu Ren (X)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: rxs0810@csu.edu.cn.

Haisong Zhang (H)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: 188111084@csu.edu.cn.

Xiaolei Zhang (X)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: Xl-Zhang@csu.edu.cn.

Qianyi Peng (Q)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: PQYicu@csu.edu.cn.

Zhiyong Liu (Z)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: 24723315@qq.com.

Li Huang (L)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: HuangL_xy@csu.edu.cn.

Fan Zhou (F)

Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Electronic address: zhoufan_2005@csu.edu.cn.

Yuhang Ai (Y)

Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: ayhicu1978@csu.edu.cn.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH